(Q28368237)

4

object named as

T Eskes

0 references

author name string

E Schoondermark-Van de Ven

1

0 references

W Melchers

2

0 references

W Camps

3

0 references

J Meuwissen

5

0 references

J Galama

Antimicrobial Agents and Chemotherapy

6

0 references

language of work or name

English

0 references

publication date

September 1994

0 references

published in

0 references

volume

38

0 references

issue

9

0 references

page(s)

1930-6

0 references

cites work

In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Rapid and simple method for purification of nucleic acids

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Avoiding false positives with PCR

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

In vitro assessment of antimicrobial agents against Toxoplasma gondii

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Identification of Toxoplasma gondii infections by BI gene amplification

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Treatment of toxoplasmosis in the pregnant mother and newborn child

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Toxoplasma and Toxoplasmosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

In vitro measurement of the inhibitory effect of macrolides, lincosamides and synergestines on the growth of Toxoplasma gondii

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Pharmacokinetics of spiramycin in man.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Congenital toxoplasmosis. A prospective study of 378 pregnancies

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284664

Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection

27 November 2018

1 reference

12 December 2020

Pathogenesis of limb and facial malformations induced by pyrimethamine in the rat

1 reference

12 December 2020

Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment

1 reference

12 December 2020

Congenital Toxoplasmosis: An Experimental Study in Rhesus Monkeys for Transmission and Prenatal Diagnosis

1 reference

12 December 2020

Postponed spiramycin treatment of acute toxoplasmosis in white mice

1 reference

12 December 2020

[Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole]

1 reference

12 December 2020

Failure of spiramycin to prevent neurotoxoplasmosis in immunosuppressed patients

1 reference

12 December 2020

[Fetomaternal therapeutic follow-up of spiramycin during pregnancy]

1 reference

12 December 2020